Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Preveceutical Medical Inc PRVCF


Primary Symbol: C.PREV

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).


CSE:PREV - Post by User

Post by LONAMIS777on Jan 14, 2021 2:26pm
249 Views
Post# 32298417

Great deal

Great dealJust bought another chunk of shares... Long-term view here is promising...

Analytics look healthy here for a buy, with the bid to ask ratio respectively sitting at 3308/238 which is a raio of over10 to 1 buyers to sellers. Volume just over half a million and morning star quant report for weds Jan 13 2020, gives a fair market value of $0.05 to the current $0.02 sp, which is a bargain at a 42% discount to value, and a moderate score for financial health...

Wth all that said the company has no economic moat and has yet to bring anything of value to the market, so as always proceed with caution and only risk what you can afford to lose...

I am not giving financial advice just stating my opinion based on my observation of the facts, as always do your own dd (due diligence) and come to your own conclusions...

GSTA THE LONGS
<< Previous
Bullboard Posts
Next >>